These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17997887)
21. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender. Daripally S; Nallapalle SR; Katta S; Prasad VV Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167 [TBL] [Abstract][Full Text] [Related]
22. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer. Sung WW; Wang YC; Cheng YW; Lee MC; Yeh KT; Wang L; Wang J; Chen CY; Lee H Clin Cancer Res; 2011 Sep; 17(18):5991-9. PubMed ID: 21807637 [TBL] [Abstract][Full Text] [Related]
23. [Gene variance in microsomal epoxide hydrolase and the susceptibility of coal workers' pneumoconiosis]. Chen C; Wang L; Yang J; Wang T; Ji X; Wu B; Han R; Ni C Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Jul; 33(7):492-5. PubMed ID: 26653643 [TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions. Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830 [TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes. Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803 [TBL] [Abstract][Full Text] [Related]
26. [Association between Fas/Fas L genes promoter polymorphisms and pathogenic risk of cervical cancer]. Li H; Guo HY; Sun T; Zhou YF; Lin DX; Zhang WH; Qiao J Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):38-41. PubMed ID: 19538867 [TBL] [Abstract][Full Text] [Related]
27. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran. Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044 [TBL] [Abstract][Full Text] [Related]
28. FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. Sun T; Zhou Y; Li H; Han X; Shi Y; Wang L; Miao X; Tan W; Zhao D; Zhang X; Guo Y; Lin D J Exp Med; 2005 Oct; 202(7):967-74. PubMed ID: 16186185 [TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer. Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174 [TBL] [Abstract][Full Text] [Related]
30. [Polymorphisms of FAS and FASL genes and susceptibility of silicosis]. Wu F; Qu YB; Sun P; Ji F; Qiu YL; Miao WB; Wang W; Jin RF; Xia ZL Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):7-11. PubMed ID: 18302883 [TBL] [Abstract][Full Text] [Related]
31. [Annexin A5 gene polymorphism (-1C/T) and the susceptibility to pneumoconiosis in coal works]. Wang T; Wang SS; Hou ZG; Ji XM; Song ZF; Jia XM; Wang ML; Ni CH Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Apr; 30(4):246-9. PubMed ID: 22804929 [TBL] [Abstract][Full Text] [Related]
32. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma. Zhang W; Li C; Wang J; He C Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365 [TBL] [Abstract][Full Text] [Related]
33. Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation. Sun Z; Ling M; Chang Y; Huo Y; Yang G; Ji Y; Li Y Connect Tissue Res; 2013; 54(1):55-61. PubMed ID: 23205884 [TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction. Lai HC; Lin WY; Lin YW; Chang CC; Yu MH; Chen CC; Chu TY Gynecol Oncol; 2005 Oct; 99(1):113-8. PubMed ID: 15996722 [TBL] [Abstract][Full Text] [Related]
35. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia. Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376 [TBL] [Abstract][Full Text] [Related]
36. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy. Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626 [TBL] [Abstract][Full Text] [Related]
37. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population. Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844 [TBL] [Abstract][Full Text] [Related]
38. Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population. Zhang M; Wu C; Li B; Du W; Zhang C; Chen Z Cancer Med; 2016 Apr; 5(4):760-6. PubMed ID: 26819081 [TBL] [Abstract][Full Text] [Related]
39. Impact of Fas/Fasl Gene Polymorphisms on Susceptibility Risk and Imatinib Mesylate Treatment Response in Chronic Myeloid Leukaemia Patients. Annuar AA; Ankathil R; Mohd Yunus N; Husin A; Ab Rajab NS; Abdul Aziz AA; Ibrahim MI; Sulong S Asian Pac J Cancer Prev; 2021 Feb; 22(2):565-571. PubMed ID: 33639675 [TBL] [Abstract][Full Text] [Related]
40. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection. Jung YJ; Kim YJ; Kim LH; Lee SO; Park BL; Shin HD; Lee HS Intervirology; 2007; 50(5):369-76. PubMed ID: 17938571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]